Source: Pharamceutical Technology

Gladstone: InvisiShield and Gladstone partner to develop intranasal preventatives

The collaboration will develop intranasal preventatives for influenza, respiratory syncytial virus, and SARS-CoV-2.

Read full article »
Gladstone's Competitors | Gladstone's News | Gladstone's Financials
Stay up-to-date with the latest news on Gladstone
Est. Annual Revenue
$25-100M
Est. Employees
500-1.0K
Robert Wicks's photo - CEO of Gladstone

CEO

Robert Wicks

CEO Approval Rating

89/100

Read more
Stay up-to-date with the latest news on Gladstone